BridgeMD
New treatment option for Adolescent HIV Infection
Official title Scale-up of an Evidence-based Adolescent Transition Package to Support Transitional Care Among Youth Living With HIV
ClinicalTrials.gov ID: NCT06924073
What this study is testing
- What it's testing
- Ending the HIV epidemic for youth living with HIV will require implementation and optimization of evidence-based interventions that address barriers to treatment. The proposed implementation study will test a youth-led data-driven implementation strategy to scale-up an evidence-based Adolescent Transition Package (ATP) aimed at improving transition processes and post-transition clinical outcomes for youth living with HIV in Kenya.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 10 and older. Healthy volunteers may be eligible.
You may be able to join if
- Healthcare providers
- ≥18 years of age
- Employed at one of the 32 facilities in the RCT
- Provides HIV services to adolescents affiliated within their clinic Adolescents and youth living with HIV
- Between 15-24 years of age (focus group discussions, surveys) or between 10-24 years of age (offered the intervention)
You likely can't join if
- Any individual who meets the following criteria will be excluded from participation in this study:
- \- Conditions that would place the individual at increased risk or preclude the individual's full compliance with or completion of the study
See the full eligibility criteria
- Healthcare providers
- ≥18 years of age
- Employed at one of the 32 facilities in the RCT
- Provides HIV services to adolescents affiliated within their clinic Adolescents and youth living with HIV
- Between 15-24 years of age (focus group discussions, surveys) or between 10-24 years of age (offered the intervention)
- Receives HIV clinical care at one of the clinics included in the study
- Attended clinic ≥1 time following intervention implementation
- Any individual who meets the following criteria will be excluded from participation in this study:
- \- Conditions that would place the individual at increased risk or preclude the individual's full compliance with or completion of the study
The study team makes the final eligibility decision.
Where it's taking place
- Awendo, Kenya
- Gatundu, Kenya
- Kiambu, Kenya
- Kikuyu, Kenya
- Limuru, Kenya
- Migori, Kenya
- Nairobi, Kenya
- Rongo, Kenya
- Ruiru, Kenya
- Thika, Kenya
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 10 years and older. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Awendo, Kenya; Gatundu, Kenya; Kiambu, Kenya; Kikuyu, Kenya; Limuru, Kenya; Migori, Kenya and 4 more location(s). Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.